reported last year, Andersen and colleagues showed that as many as 8% of patients have persistent pain a year after their stroke.2 Although only a small proportion of stroke victims will have chronic pain, because stroke is so common, pain must affect surprisingly large numbers of people, many of whom will not necessarily be under medical review. The purpose of this editorial is to draw attention to the importance of this "hidden" disorder, place it within the context of central pain, and briefly summarise some clinical aspects and possible mechanisms.
Pain after stroke is an example of central pain, defined as "regional pain caused by a primary lesion or dysfunction in the CNS, usually associated with abnormal sensibility to temperature and to noxious stimulation."3 (For reviews on central pain, see 4 7 ; for a historical review of the terminology and development of the concept, see8.) WXhereas stroke is the commonest cause, followed by multiple sclerosis9 11 and spinal cord injury,'2 there are numerous other neurological disorders that can give rise to central pain; cerebral causes include tumours,'3 penetrating head injuries,'4 epilepsy,' 157 Parkinson's disease,8I " and motor neuron disease2'; and spinal causes include syringomyelia,2'22 spinal cord infarction,2 and tumours. 4 6 Central pain may also follow surgical lesions of the nervous system,6 24 but curiously it rarely follows blunt head injury or craniotomy. Pain after stroke can be considered the epitome of central pain, and many of the clinical features and therapeutic strategies employed in this condition are common to other conditions causing central pain.
From thalamic syndrome to central poststroke pain The finding that strokes could give rise to pain became established in 1906 with the famous paper entitled Le syndrome thalamique by Dejerine and Roussy. 25 They described the postmortem findings in three patients who had pain that followed stroke. They also correlated the clinical features with the pathological findings of a lesion that included "the external nucleus of the thalamus (lateral and posterior portions especially) . . .", and defined the thalamic syndrome-a term they introduced as a mild hemiplegia without contractures, persistent superficial hemianaesthesia (in some cases replaced by superficial hyperaesthesia) with impaired deep sensation, mild hemiataxia and astereognosis, and in addition there might be choreoathetosis on the paralysed side and "sharp, enduring, paroxysmal, often intolerable pain on the hemiplegic side which does not respond to any analgesic treatment".25
Despite Dejerine and Roussy25 reporting that pain was an inconstant feature, the thalamic syndrome is oftenincorrectly-thought of as being synonymous with pain that follows stroke. Furthermore, it soon became apparent that similar pain could arise after strokes that affect not just the thalamus but many and possibly any part of the central somatosensory pathways.4 As a result, the term "thalamic syndrome" for the painful condition is neither historically correct nor accurate in respect of the clinical features and has been replaced by the term "central poststroke pain".
The nature of the vascular lesion Why some, and possibly younger,' patients should develop pain, why most strokes remain painless, and why pain tends not to occur when there is severe hemiplegia are unknown. There is no relation between the pain and the arterial territory involved, nor the size of the lesion, and no single structure has been implicated in the generation of the pain.
Studies with CT26 and more recently MRI27 28 have disclosed the numbers and sites of vascular lesions which may be giving rise to pain. Sometimes multiple, these lesions often include small infarcts especially in the brainstem, and tiny infarcts could account for the pain in those patients in which this is the only symptom. Often, however, it is difficult to correlate any specific lesion on the scan with the site of origin of the pain. Very infrequent after midbrain infarcts, pain is commonest after thalamic infarcts but even then it is unusual; Bogousslavsky et al reported pain in only three of 42 Recently the sensory changes accompanying the pain have been studied more extensively. The area of pain is within or less than that of the sensory deficit,28 which often shows allodynia or hyperalgesia. The cardinal findings are that appreciation of pinprick and temperature is nearly always impaired,' 2635 and there is almost always a raised threshold to warm and cold detection and to a lesser extent also to painful heat and pain.2835 Modalities subserved by the posterior columns are less commonly affected, although in patients with poststroke pain, dysaesthesiae after physiological stimuli including light touch and movement or electrical stimulation are probably mediated by the posterior columns. 37 Confirmation of the typical spinothalamic dysfunction and small fibre mediated involvement has come from evoked potential studies. These demonstrate that laser evoked cerebral potentials are usually abnormal when elicited from the affected side of patients with poststroke pain and in whom there is impairment of spinothalamic function,'8 compared with normal electrically evoked sensory potentials subserved by large diameter fibres. '9 Patients with strokes and impaired spinothalamic function may, however, not experience pain, and it seems that a lesion affecting the spinothalamic system "is a necessary but not sufficient condition" for the development of poststroke pain. 28 Patients often show features of autonomic impairment on the painful side. The painful area tends to be cooler and vasoconstricted; changes in sweating are inconstant.' Treatment It is distressing to patients and disheartening for doctors to realise that the original finding of Dejerine and Roussy2' as to the ineffectiveness of treatment remains true for the majority of patients, and many would not share the view that pain relief can be achieved in almost two thirds of patients.40 New approaches therefore remain the best hope for the future. The principles of treatment are first to treat any nociceptive components, related, for instance, to skin changes, infection, and musculoskeletal factors including abnormal posture. This is because these peripheral factors are generally easier to treat than the central pain, and because abnormal peripheral input may enhance central pain.
DRUGS
Numerous types of drugs ranging from phenothiazines to levodopa have been tried in the treatment of poststroke pain, and occasional patients unpredictably respond, for example, to anticonvulsants such as carbamazepine.4' Few drugs, however, have stood the test of time, and on the rare occasions that controlled studies have been undertaken, drugs such as naloxone which were initially thought valuable have often been found to be ineffective. 42 Most information pertains to tricyclic antidepressant drugs, and those with a non-selective chemical profile may be associated with greater efficacy. Some patients in pain who are also depressed may report that their depression
has resolved yet their pain persists; this, and the fact that in some patients the relief of pain occurs more rapidly than might a typical antidepressant effect, suggest that such drugs mediate relief of pain independently of effects on depression414' and thus through different mechanisms.
Amitriptyline has been found to be more effective than placebo, and whereas considerable variation in dosage has been used, greater pain relief may be achieved when the plasma concentration is greater than 300 nm/l. Many ablative procedures on the peripheral and central nervous system, particularly thalamotomy and mesencephalotomy, have been attempted to interrupt afferent pain conducting pathways. The realisation that neurogenic pain tends to be unaffected by such procedures and the tendency in successful cases for late recurrence of pain, however, have led to the abandonment of most destructive procedures "except in some very well defined and rare conditions." 50 Sympathetic blockade has been used, particularly when there is hyperpathia, but it is only rarely helpful. It is minimally invasive in experienced hands, although regional intravenous sympathetic blockade carries less risk. Curiously, this peripheral blockade has been reported as beneficial even when the cause of pain is central, although information from controlled studies is lacking.5' While enthusiasm for lesioning procedures has waned, there has been increasing interest in stimulation procedures, and various parts of the nervous system have been stimulated in an attempt to excite ill understood ascending or descending pathways that may subserve inhibitory processes. As with ablative techniques, few of these methods have been evaluated by appropriate controlled studies, any improvement in pain may wane, often only a few patients have been studied, patients included in trials often have heterogeneous conditions, and follow up tends to be for a short period and is rarely undertaken by independent observers.
A practical approach is to start with transcutaneous electrical nerve stimulation (TENS). This non-invasive and non-destructive technique is simple, safe, and cheap. It can be tried in almost any patient, and has been reported as occasionally improving central pain after strokes.34 However, TENS may exacerbate central pain during stimulation and obviously then needs to be discontinued. Deep brain stimulation is invasive but relatively nondestructive. 52 The regions that have most commonly been stimulated include the somatosensory areas of the ventrobasal thalamus (including the ventroposterior lateral and medial nuclei), the periventricular and periaqueductal grey matter, and adjacent nuclei. 
Mechanisms
The mechanisms subserving poststroke and other central pains have been considered for a century and remain unknown. Whereas there has been recent interest in the effects of plasticity59 and in alterations of affective processes in the anterior cingulate60 and subfrontal cortex in respect of how pain in humans is experienced, two main mechanisms have been postulated. These are excitation in damaged sensory pathways and the effects of impaired inhibitory pathways.
Evidence for abnormal excitation comes from several sources. Referred to above, epilepsy can be associated with pain, and occasionally epileptic attacks with a painful aura follow strokes.' 61 Furthermore, epileptic activity has been recorded from the midbrain and thalamus of patients with poststroke pain by some workers62 63 but not others.`6 Disconnection has been considered a possible factor in patients with pain related to parietal strokes that interrupt sensory pathways between thalamus and cortex,30 and the sequelae may represent an example of deafferentation. Deafferentation phenomena, perhaps akin to changes seen in denervation supersensitivity, have been much discussed in relation to those neurophysiological changes in the thalamus that occur in patients with poststroke pain65 and other central pains.66 These changes include abnormal spontaneous and evoked burst activity,67 presence of this activity in medial as well as posteroventolateral neurons,68
and loss of point to point relation between thalamic neurons and their usual receptive and projected fields. 69 Whether such changes relate specifically to pain, however, remains unclear. Thus microelectrode studies in 29 patients with central poststroke pain showed both normal and abnormal receptive and projected fields, leading Tasker in a review that included this study to comment: "Burst-firing cells and somatotopographical reorganisation were found in most patients and bore no relationship to their pain."69 Again, whereas neurogenic pain may be associated with cells in the thalamus which show bursting activity with characteristics typical of low threshold calcium spikes, the tendency to generate such bursts is also seen in various other yet painless disorders of the CNS that are associated with positive phenomena.70 Furthermore, not only is it unresolved whether neurogenic pain is necessarily associated with excitation in spinothalamic pathways at thalamic or cortical level, but poststroke pain has also been reported in patients whose entire thalamus on one side has been infarcted.7' What structures might subserve pain when extensive damage has occurred in the CNS and the question of involvement of ipsilateral and infrathalamic pathways have not been established.65
Damage to central inhibitory pathways is likely to be another mechanism involved in the causation of central pain (for review of central inhibition, see72). Noradrenaline and serotonin are implicated both in the function of these inhibitory pathways and in the effects of tricyclic antidepressants, effects which include the relief of pain. Enhancement of inhibition, either chemically or by means of peripheral and central stimulation, may thus explain the mechanisms underlying some of the therapeutic strategies described.
Although several studies of functional imaging in pain after strokes have been reported, their contribution to understanding poststroke and other central pains is unclear. The bewildering use of different types of metabolic studies using different techniques, the different clinical features of the patients, and the different brain areas that have been investigated mean that correlation of the findings with the clinical phenomena is not possible at present. 73 Thus in 1988 a PET study by Laterre and colleagues showed decreased glucose metabolism in the affected posterior thalamus in a patient with poststroke thalamic pain.74 By comparison, a SPECT study of four patients with central poststroke pain, two of whom had hyperpathia, indicated a relative hyperactivity of the thalamus contralateral to the hyperpathic side.75 This hyperactivity was present only in those two patients with hyperpathia; the lesion was thalamic in one patient and in the subcortical parietal region in the other. In another SPECT study assessing cortical involvement in five patients with central pain, in two (one with central poststroke pain, the other with anaesthesia dolorosa) there was decreased parietal blood flow contralateral to the painful side76; a similar finding was noted by Lee et al in three patients with thalamic poststroke pain.77 A PET study by Hirato and colleagues disclosed preserved regional oxygen consumption and cortical glucose metabolism in brain structures except in the affected thalamus of patients with thalamic strokes and pain, but in strokes in the putamen and in thalamic strokes without pain, regional cerebral oxygen consumption was reduced.78 These authors suggested that different pathophysiological mechanisms might occur under different circumstances, although conclusions could not be reached-a view evidently applicable to all such studies at present.
It should also be emphasised that these changes in functional imaging may not necessarily relate specifically to central poststroke pain. This is because, as with the physiological phenomena recorded from the thalamus,7980 the widespread changes seen on PET are also seen in painful conditions that arise outside the brain.81-83 These PET changes included an unexpected decreased thalamic activity contralateral to the symptomatic side in patients whose pain arises peripherally, a finding reminiscent of that reported in the patient with central pain referred to above.74 Apart from this question of specificity, it also remains unclear whether the physiological and functional imaging findings relate to the experience of pain, to mechanisms that inhibit pain, or to epiphenomena.
At the end of this century in which pain after stroke became recognised, much has been learnt about the clinical features of this and related conditions, and new techniques have started to contribute to understanding the underlying pathophysiology. It has been established that central poststroke pain, originally thought an uncommon neurological curiosity, is in reality an important and underrecognised condition. Both spontaneous and evoked pains and other sensory disturbances may be present, the pain is often burning in quality, and when sensory changes are slight the most characteristic finding is impaired temperature appreciation in and surrounding the painful area. Management consists of treatment of secondary or associated musculoskeletal and other nociceptive components, drug therapy with tricyclic antidepressants sometimes combined later with anticonvulsants such as carbamazepine, trials of transcutaneous electrical nerve stimulation and occasionally sympathetic blockade, and only very rarely resort to deep brain or the currently experimental motor cortex stimulation. Psychological methods of pain management and occasionally referral for a psychiatrist's opinion may also be very valuable. It is to be hoped that further developments in therapy will reach fruition early in the next century.
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